Aethlon Medical (NASDAQ: AEMD)
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-08 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-06-23 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Aethlon Medical (NASDAQ: AEMD) through any online brokerage.
Other companies in Aethlon Medical’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Talis Biomedical (NASDAQ:TLIS), Tivic Health Systems (NASDAQ:TIVC) and Motus GI Hldgs (NASDAQ:MOTS).
The latest price target for Aethlon Medical (NASDAQ: AEMD) was reported by HC Wainwright & Co. on Friday, June 25, 2021. The analyst firm set a price target for 9.00 expecting AEMD to rise to within 12 months (a possible 514.33% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aethlon Medical (NASDAQ: AEMD) is $1.465 last updated May 27, 2022, 8:00 PM UTC.
There are no upcoming dividends for Aethlon Medical.
Aethlon Medical’s Q1 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Aethlon Medical.
Aethlon Medical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.